The firm's analysts think highly of Target's long-term prospects, despite cutting their price target for the fifth time since ...

BMO Capital cut Terns Pharmaceuticals' price target from $26 to $15, citing costlier capital conditions despite maintaining ...

An assessment by UBS says Bristol Myers Squibb and Pfizer would be worst hit among US companies if Mr Trump’s threatened ...

Investors are closely monitoring the performance of Indian pharma companies in the March 2025 quarter and their ability to ...

Nissan Motor unveiled sweeping new cost cuts, saying it would eliminate 11,000 more jobs and close 7 plants, capping a ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

Global pharmaceutical company Pfizer (NYSE:PFE) in Q1 CY2025, with sales falling 7.8% year on year to $13.72 billion. The ...

Royal Caribbean Group reported first-quarter earnings that rose above expectations, and was one of the rare companies to raise their full-year outlook in the face of “heightened” uncertainties ...

In an executive order Monday morning, Trump announced plans to reduce drug prices by 30 to 80%.

Stock futures soared on Monday after a trade deal to substantially lower tariffs was reached with China over the weekend. According to a joint statement, Trump's "reciprocal" tariffs on China will ...

But when a dividend yield reaches ultrahigh levels, investors can feel a heightened level of uncertainty. Wondering if Pfizer ...